drugset / Trial / NCT02607683
Phase 2b/3 Study of XAF5 Ointment for Steatoblepharon (Undereye Bags)
RandomizedParallel-groupTriple-blindTreatment
Summary
This randomized, placebo-controlled, double-masked, Phase 2b/Phase 3 study will assess the efficacy of two different concentrations of XAF5 Ointment for reduction of lower lid steatoblepharon (undereye bags).
Timeline
- Start
- 2016-01-01
- Primary completion
- 2016-09-19
- Completion
- 2016-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | XAF5 | Unknown | 0.035 % | Topical |
| Subject | XAF5 | Unknown | 0.1 % | Topical |